Nomura Asset Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $58.7M | Sell |
2,091,873
-13,230
| -0.6% | -$352K | 0.15% | 137 |
|
|
2025
Q4 | $52.4M | Buy |
2,105,103
+43,248
| +2% | +$1.09M | 0.13% | 163 |
|
|
2025
Q3 | $52.5M | Sell |
2,061,855
-50,793
| -2% | -$1.25M | 0.14% | 159 |
|
|
2025
Q2 | $51.2M | Buy |
2,112,648
+171,223
| +9% | +$3.99M | 0.14% | 156 |
|
|
2025
Q1 | $49.2M | Buy |
1,941,425
+190,362
| +11% | +$4.98M | 0.15% | 155 |
|
|
2024
Q4 | $46.5M | Buy |
1,751,063
+1,361
| +0.1% | +$36.9K | 0.14% | 163 |
|
|
2024
Q3 | $50.6M | Buy |
1,749,702
+92,596
| +6% | +$2.7M | 0.16% | 150 |
|
|
2024
Q2 | $46.4M | Buy |
1,657,106
+7,493
| +0.5% | +$206K | 0.16% | 138 |
|
|
2024
Q1 | $45.8M | Sell |
1,649,613
-164,979
| -9% | -$4.58M | 0.17% | 138 |
|
|
2023
Q4 | $52.2M | Buy |
1,814,592
+29,003
| +2% | +$877K | 0.22% | 111 |
|
|
2023
Q3 | $59.2M | Sell |
1,785,589
-60,112
| -3% | -$2.13M | 0.28% | 76 |
|
|
2023
Q2 | $67.7M | Buy |
1,845,701
+165,088
| +10% | +$6.43M | 0.31% | 65 |
|
|
2023
Q1 | $68.6M | Buy |
1,680,613
+98,153
| +6% | +$4.24M | 0.36% | 59 |
|
|
2022
Q4 | $81.1M | Sell |
1,582,460
-25,419
| -2% | -$1.22M | 0.47% | 45 |
|
|
2022
Q3 | $70.4M | Sell |
1,607,879
-132,599
| -8% | -$6.44M | 0.45% | 45 |
|
|
2022
Q2 | $91.3M | Buy |
1,740,478
+284,075
| +20% | +$14.5M | 0.57% | 31 |
|
|
2022
Q1 | $75.4M | Sell |
1,456,403
-67,394
| -4% | -$3.5M | 0.41% | 49 |
|
|
2021
Q4 | $90M | Buy |
1,523,797
+281,323
| +23% | +$13.9M | 0.45% | 42 |
|
|
2021
Q3 | $53.4M | Buy |
1,242,474
+57,609
| +5% | +$2.55M | 0.3% | 79 |
|
|
2021
Q2 | $46.4M | Buy |
1,184,865
+79,124
| +7% | +$3.08M | 0.27% | 88 |
|
|
2021
Q1 | $40.1M | Buy |
1,105,741
+8,746
| +0.8% | +$311K | 0.26% | 94 |
|
|
2020
Q4 | $40.4M | Sell |
1,096,995
-8,408
| -0.8% | -$308K | 0.27% | 83 |
|
|
2020
Q3 | $38.5M | Sell |
1,105,403
-53,488
| -5% | -$1.88M | 0.3% | 78 |
|
|
2020
Q2 | $36M | Sell |
1,158,891
-56,542
| -5% | -$1.92M | 0.3% | 74 |
|
|
2020
Q1 | $37.6M | Buy |
1,215,433
+31,289
| +3% | +$1.07M | 0.39% | 64 |
|
|
2019
Q4 | $44M | Sell |
1,184,144
-117,451
| -9% | -$4.18M | 0.39% | 58 |
|
|
2019
Q3 | $44.4M | Sell |
1,301,595
-55,530
| -4% | -$2.02M | 0.42% | 55 |
|
|
2019
Q2 | $55.8M | Buy |
1,357,125
+46,293
| +4% | +$1.84M | 0.55% | 40 |
|
|
2019
Q1 | $52.8M | Sell |
1,310,832
-152,369
| -10% | -$6.1M | 0.52% | 43 |
|
|
2018
Q4 | $60.6M | Buy |
1,463,201
+84,627
| +6% | +$3.51M | 0.68% | 28 |
|
|
2018
Q3 | $57.6M | Sell |
1,378,574
-45,907
| -3% | -$1.77M | 0.56% | 40 |
|
|
2018
Q2 | $49M | Sell |
1,424,481
-24,201
| -2% | -$827K | 0.51% | 45 |
|
|
2018
Q1 | $48.8M | Buy |
1,448,682
+100,012
| +7% | +$3.44M | 0.53% | 46 |
|
|
2017
Q4 | $46.3M | Buy |
1,348,670
+44,265
| +3% | +$1.51M | 0.54% | 47 |
|
|
2017
Q3 | $44.2M | Buy |
1,304,405
+184,902
| +17% | +$5.94M | 0.57% | 42 |
|
|
2017
Q2 | $35.7M | Buy |
1,119,503
+92,330
| +9% | +$2.91M | 0.48% | 52 |
|
|
2017
Q1 | $33.3M | Sell |
1,027,173
-194,354
| -16% | -$6.13M | 0.47% | 51 |
|
|
2016
Q4 | $37.7M | Buy |
1,221,527
+12,281
| +1% | +$375K | 0.68% | 29 |
|
|
2016
Q3 | $38.9M | Sell |
1,209,246
-117,614
| -9% | -$3.93M | 0.7% | 30 |
|
|
2016
Q2 | $44.3M | Sell |
1,326,860
-123,854
| -9% | -$3.95M | 0.83% | 20 |
|
|
2016
Q1 | $40.8M | Buy |
1,450,714
+95,351
| +7% | +$2.72M | 0.78% | 22 |
|
|
2015
Q4 | $41.5M | Buy |
1,355,363
+5,427
| +0.4% | +$171K | 0.8% | 20 |
|
|
2015
Q3 | $40.2M | Sell |
1,349,936
-32,966
| -2% | -$1.06M | 0.81% | 20 |
|
|
2015
Q2 | $44M | Sell |
1,382,902
-13,151
| -0.9% | -$429K | 0.81% | 17 |
|
|
2015
Q1 | $46.1M | Buy |
1,396,053
+380,112
| +37% | +$12.1M | 0.82% | 19 |
|
|
2014
Q4 | $30.3M | Sell |
1,015,941
-56,832
| -5% | -$1.63M | 0.53% | 51 |
|
|
2014
Q3 | $30M | Sell |
1,072,773
-25,928
| -2% | -$728K | 0.53% | 52 |
|
|
2014
Q2 | $31M | Sell |
1,098,701
-90,339
| -8% | -$2.58M | 0.57% | 42 |
|
|
2014
Q1 | $36.2M | Sell |
1,189,040
-39,093
| -3% | -$1.17M | 0.66% | 30 |
|
|
2013
Q4 | $35.7M | Sell |
1,228,133
-149,087
| -11% | -$4.34M | 0.64% | 32 |
|
|
2013
Q3 | $37.5M | Sell |
1,377,220
-716,898
| -34% | -$19.5M | 0.71% | 27 |
|
|
2013
Q2 | $55.7M | Buy |
+2,094,118
| New | +$57.9M | 1.1% | 14 |
|
Other funds holding PFE
VCM
VPM
Nomura Asset Management's PFE Position: Q1 2026 in Review
Nomura Asset Management reduced its Pfizer (PFE) stake by 0.63% in Q1 2026, selling an estimated $352K and leaving 2,091,873 shares worth $58.7M. The position accounts for 0.15% of the portfolio, ranked #137.
Nomura Asset Management first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $91.3M in Q2 2022. 2,936 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Nomura Asset Management held 2,091,873 shares of Pfizer worth $58.7M as of Q1 2026.
- Nomura Asset Management sold 13,230 Pfizer shares in Q1 2026, an estimated $352K.
- Pfizer made up 0.15% of Nomura Asset Management's portfolio in Q1 2026, its #137 holding.
- Nomura Asset Management first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
- Nomura Asset Management's Pfizer position peaked at $91.3M in Q2 2022.
- 2,936 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Nomura Asset Management's 13F filing for Q1 2026, filed 11 May 2026.